Dydrogesterone Oral Tablet

DRUG4 trials

Sponsors

Assiut University, The University of Hong Kong, CRG UZ Brussel, Kasr El Aini Hospital

Conditions

Abortion in First TrimesterAssisted Reproductive TechniquesDydrogesteroneGenital Diseases, FemaleGenital Diseases, MaleGnRH AntagonistHormonesHormones, Hormone Substitutes, and Hormone Antagonists

Phase 2

Progesterone to Prevent Preterm Delivery

The University of Hong KongPreterm Birth

Start: 2019-01-15End: 2023-01-31Target: 1714Updated: 2019-04-10

Phase 3

PPOS Protocol Versus GnRH Anatagonist for Expected Normal Responder Patients Undergoing ART : a Randomized Clinical Trial

CompletedNCT06868576

Kasr El Aini HospitalAssisted Reproductive Techniques, GnRH Antagonist, PPOS

Start: 2023-01-03End: 2025-02-28Updated: 2025-03-11

Phase 4

Progesterone and Doppler in Recurrent Abortion

Assiut UniversityAbortion in First Trimester

Start: 2017-10-01End: 2019-12-05Target: 50Updated: 2017-09-08

Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI

CompletedNCT03677336

CRG UZ BrusselDydrogesterone, Genital Diseases, Female, Genital Diseases, Male +7

Start: 2019-05-01End: 2020-08-24Updated: 2020-12-17

Related Papers

Early universal use of oral progesterone for prevention of preterm births in singleton pregnancy (SINPRO study): protocol of a multicenter, randomized, double-blind, placebo-controlled trial.

2020-01-305 citations